Year |
Citation |
Score |
2022 |
Alaskar A, Abdulraqeb Ali A, Hassan S, Shinwari Z, Alaiya A, von Holzen U, Miller L, Kulik G. Inhibition of signaling downstream of beta-2 adrenoceptor by propranolol in prostate cancer cells. The Prostate. PMID 36373761 DOI: 10.1002/pros.24455 |
0.379 |
|
2021 |
Ali A, Kulik G. Signaling Pathways That Control Apoptosis in Prostate Cancer. Cancers. 13. PMID 33668112 DOI: 10.3390/cancers13050937 |
0.379 |
|
2020 |
Hassan MS, Pullikuth A, Nelson KC, Flores A, Karpova Y, Baiz D, Zhu S, Sui G, Huang Y, D'Agostino R, Hemal A, von Holzen U, Debinski W, Kulik G. Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Molecular Cancer Research : McR. PMID 32928910 DOI: 10.1158/1541-7786.Mcr-19-1037 |
0.509 |
|
2019 |
Kulik G. ADRB2-Targeting Therapies for Prostate Cancer. Cancers. 11. PMID 30871232 DOI: 10.3390/Cancers11030358 |
0.486 |
|
2018 |
Cantrell W, Huang Y, Menchaca AA, Kulik G, Welker ME. Synthesis and PI3 Kinase Inhibition Activity of a Wortmannin-Leucine Derivative. Molecules (Basel, Switzerland). 23. PMID 30036994 DOI: 10.3390/Molecules23071791 |
0.678 |
|
2018 |
Wright EW, Nelson RA, Karpova Y, Kulik G, Welker ME. Synthesis and PI3 Kinase Inhibition Activity of Some Novel Trisubstituted Morpholinopyrimidines. Molecules (Basel, Switzerland). 23. PMID 29996482 DOI: 10.3390/Molecules23071675 |
0.681 |
|
2018 |
Nelson RA, Schronce T, Huang Y, Albugami A, Kulik G, Welker ME. Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines. Molecules (Basel, Switzerland). 23. PMID 29973512 DOI: 10.3390/Molecules23071628 |
0.677 |
|
2017 |
Sastry KS, Chouchane AI, Wang E, Kulik G, Marincola FM, Chouchane L. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling. Cell Death & Disease. 8: e2844. PMID 28569785 DOI: 10.1038/cddis.2017.226 |
0.394 |
|
2016 |
Zhang Q, Wan M, Shi J, Horita DA, Miller LD, Kute TE, Kridel SJ, Kulik G, Sui G. Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation. Journal of Molecular Cell Biology. PMID 26762111 DOI: 10.1093/Jmcb/Mjw002 |
0.329 |
|
2015 |
Kulik G. Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network. Asian Journal of Andrology. 17: 471-4. PMID 25578933 DOI: 10.4103/1008-682X.143749 |
0.408 |
|
2014 |
Kulik G. Precision therapy to target apoptosis in prostate cancer. Experimental Oncology. 36: 226-30. PMID 25537214 |
0.392 |
|
2014 |
Sastry KS, Al-Muftah MA, Li P, Al-Kowari MK, Wang E, Ismail Chouchane A, Kizhakayil D, Kulik G, Marincola FM, Haoudi A, Chouchane L. Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells. Cell Death and Differentiation. 21: 1936-49. PMID 25215949 DOI: 10.1038/cdd.2014.140 |
0.319 |
|
2014 |
Hassan S, Karpova Y, Flores A, D'Agostino R, Danhauer SC, Hemal A, Kulik G. A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies. International Urology and Nephrology. 46: 505-10. PMID 24057680 DOI: 10.1007/S11255-013-0513-0 |
0.457 |
|
2013 |
Sun X, Bao J, Nelson KC, Li KC, Kulik G, Zhou X. Systems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapy. Plos Computational Biology. 9: e1003358. PMID 24339759 DOI: 10.1371/journal.pcbi.1003358 |
0.388 |
|
2013 |
Hassan S, Karpova Y, Flores A, D'Agostino R, Kulik G. Surgical stress delays prostate involution in mice. Plos One. 8: e78175. PMID 24223137 DOI: 10.1371/Journal.Pone.0078175 |
0.433 |
|
2013 |
Baiz D, Hassan S, Choi YA, Flores A, Karpova Y, Yancey D, Pullikuth A, Sui G, Sadelain M, Debinski W, Kulik G. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer. Neoplasia (New York, N.Y.). 15: 1172-83. PMID 24204196 DOI: 10.1593/Neo.13986 |
0.566 |
|
2013 |
Yancey D, Nelson KC, Baiz D, Hassan S, Flores A, Pullikuth A, Karpova Y, Axanova L, Moore V, Sui G, Kulik G. BAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells. Plos One. 8: e74561. PMID 24040284 DOI: 10.1371/Journal.Pone.0074561 |
0.557 |
|
2013 |
Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer. The American Journal of Pathology. 183: 1339-50. PMID 23938323 DOI: 10.1016/J.Ajpath.2013.06.027 |
0.312 |
|
2013 |
Boyacioglu O, Stuart CH, Kulik G, Gmeiner WH. Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages. Molecular Therapy. Nucleic Acids. 2: e107. PMID 23860551 DOI: 10.1038/Mtna.2013.37 |
0.322 |
|
2013 |
Welker ME, Kulik G. Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. Bioorganic & Medicinal Chemistry. 21: 4063-91. PMID 23735831 DOI: 10.1016/J.Bmc.2013.04.083 |
0.625 |
|
2013 |
Kulik G. Targeting psychoemotional stress to treat prostate cancer. Asian Journal of Andrology. 15: 362-3. PMID 23584381 DOI: 10.1038/Aja.2013.30 |
0.482 |
|
2013 |
Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D'Agostino R, Danial N, Datta SR, Kulik G. Behavioral stress accelerates prostate cancer development in mice. The Journal of Clinical Investigation. 123: 874-86. PMID 23348742 DOI: 10.1172/Jci63324 |
0.489 |
|
2013 |
Zhang Q, Wan M, Horita DA, Miller LD, Kridel SJ, Kute TE, Kulik G, Sui G. Abstract A25: Yin Yang 1 promotes AKT activation through direct protein binding Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A25 |
0.404 |
|
2012 |
Baiz D, Pinder TA, Hassan S, Karpova Y, Salsbury F, Welker ME, Kulik G. Synthesis and characterization of a novel prostate cancer-targeted phosphatidylinositol-3-kinase inhibitor prodrug. Journal of Medicinal Chemistry. 55: 8038-46. PMID 22924393 DOI: 10.1021/Jm300881A |
0.7 |
|
2012 |
Baiz D, Choi YA, Karpova Y, Yancey D, Hassan S, Sadelain M, Debinski W, Kulik G. Abstract 2748: Prostate-specific inhibition of PI3 Kinase and protein synthesis as a therapy for advanced hormone-refractory prostate cancer Cancer Research. 72: 2748-2748. DOI: 10.1158/1538-7445.Am2012-2748 |
0.529 |
|
2011 |
Baiz D, Yancey D, Choi YA, Baurin V, Karpova Y, Hassan S, Debinski W, Kulik G. Abstract 183: Loss of Bad phosphorylation and Mcl-1 expression is necessary for rapid apoptosisinduced by combination of TGFα-PE and ZSTK474 in prostate cancer cells Cancer Research. 71: 183-183. DOI: 10.1158/1538-7445.Am2011-183 |
0.528 |
|
2011 |
Hassan S, Baurin V, Karpova Y, Yancey D, Cline M, Kulik G. Abstract 10: Effect of behavioral stress on therapeutic sensitivity of prostate cancer Cancer Research. 71: 10-10. DOI: 10.1158/1538-7445.Am2011-10 |
0.496 |
|
2010 |
Hassan S, Baurin V, Karpova Y, Yancey D, Perry D, Cline M, Kulik G. Behavioral stress reduces therapeutic sensitivity of prostate cancer Brain, Behavior, and Immunity. 24: S17. DOI: 10.1016/J.Bbi.2010.07.053 |
0.414 |
|
2009 |
Smith AJ, Karpova Y, D'Agostino R, Willingham M, Kulik G. Expression of the Bcl-2 protein BAD promotes prostate cancer growth. Plos One. 4: e6224. PMID 19593445 DOI: 10.1371/Journal.Pone.0006224 |
0.532 |
|
2007 |
Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. The Journal of Clinical Investigation. 117: 1866-75. PMID 17607361 DOI: 10.1172/Jci31494 |
0.384 |
|
2007 |
Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, Carson JP, Weber MJ, Register TC, Chen YQ, Penn RB, Kulik G. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. The Journal of Biological Chemistry. 282: 14094-100. PMID 17353197 DOI: 10.1074/Jbc.M611370200 |
0.432 |
|
2006 |
Sastry KS, Karpova Y, Kulik G. Epidermal growth factor protects prostate cancer cells from apoptosis by inducing BAD phosphorylation via redundant signaling pathways. The Journal of Biological Chemistry. 281: 27367-77. PMID 16847055 DOI: 10.1074/Jbc.M511485200 |
0.522 |
|
2006 |
Sastry KS, Smith AJ, Karpova Y, Datta SR, Kulik G. Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. The Journal of Biological Chemistry. 281: 20891-901. PMID 16728406 DOI: 10.1074/Jbc.M602928200 |
0.501 |
|
2002 |
Carson JP, Behnam M, Sutton JN, Du C, Wang X, Hunt DF, Weber MJ, Kulik G. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Research. 62: 18-23. PMID 11782351 |
0.346 |
|
1999 |
Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B. Cancer Research. 59: 1449-53. PMID 10197612 |
0.488 |
|
1998 |
Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Molecular and Cellular Biology. 18: 6711-8. PMID 9774684 |
0.319 |
|
1997 |
Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Molecular and Cellular Biology. 17: 1595-606. PMID 9032287 |
0.323 |
|
Show low-probability matches. |